MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 1 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28 | -47.2% | 214,337 | +46.7% | 0.00% | – |
Q2 2023 | $53 | -34.6% | 146,100 | -15.0% | 0.00% | – |
Q1 2023 | $81 | +32.8% | 171,929 | +42.0% | 0.00% | – |
Q4 2022 | $61 | -99.7% | 121,096 | +258.3% | 0.00% | – |
Q3 2022 | $21,000 | -95.6% | 33,800 | -94.5% | 0.00% | -100.0% |
Q2 2021 | $472,000 | +221.1% | 609,152 | +333.9% | 0.00% | – |
Q1 2021 | $147,000 | -91.1% | 140,403 | -88.5% | 0.00% | -100.0% |
Q4 2020 | $1,658,000 | +704.9% | 1,219,162 | +356.6% | 0.00% | – |
Q2 2020 | $206,000 | -66.5% | 267,000 | -73.9% | 0.00% | -100.0% |
Q1 2020 | $615,000 | -9.0% | 1,024,300 | +243.8% | 0.00% | 0.0% |
Q4 2019 | $676,000 | +144.9% | 297,942 | +17.8% | 0.00% | – |
Q1 2019 | $276,000 | +122.6% | 253,000 | +87.5% | 0.00% | – |
Q3 2018 | $124,000 | +785.7% | 134,900 | +325.6% | 0.00% | – |
Q2 2018 | $14,000 | – | 31,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |